An interventional study of Multidisciplinary team (MDT) care and Acute kidney disease (AKD) clinic in Acute Kidney Injury, Renal Insufficiency, Chronic and Acute Kidney Disease, sponsored by Taipei Medical University Shuang Ho Hospital. Status unknown. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2019-10-30.
Sponsored by Taipei Medical University Shuang Ho Hospital · Not applicable, Interventional, and Health services research
Strategies to stop AKI-AKD-CKD continuum - Policy is one of the collaborative projects, Strategies to stop AKI-AKD-CKD continuum, Epidemiology, Immunology, Repair, Artificial intelligence, and Policy (EIRAP). It is aimed to study effective interventional strategies that lower the incidence of CKD among patients with AKD. The intensified AKD care to reduce CKD (ISACC trial) is a prospective, open-labeled, randomized controlled trial is designed to evaluate the efficacy of multidisciplinary team care (MDT) model and acute kidney disease (AKD) clinic visits
Acute kidney disease (AKD), defined as the ongoing renal function impairment between 7 days and 90 days following AKI, has been proposed as a window of intervention to prevent the occurrence of CKD. However, the effective therapeutic strategies of AKD care remain to be developed. We intend to conduct a prospective, randomized, open-label, behavioral interventional trial to validate the efficacy of multidisciplinary team (MDT) care model which aims to improve AKD care and to reduce de novo CKD incidence.
3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.
This study's planned enrollment of 690 is above the median of 70 across 2,640 interventional studies indexed under Kidney Diseases.
Browse Kidney Diseases studies →Taipei Medical University Shuang Ho Hospital is the lead sponsor of 100 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Experimental: Multidisciplinary team (MDT) care + Acute kidney disease (AKD) clinic Participants randomized to this arm will receive multidisciplinary team (MDT) care by a specialized medical team which is composed of nephrologist, pharmacist and dietitian. Besides intensified care, participants of this arm receive evaluation of biochemical and physiological renal function more frequently. In order to provide seamless care of this group, post-discharge acute kidney disease (AKD) clinic will also be arranged for them. Clinic visits consist of evaluation of renal function, reconciliation of medication and steering necessity of renal replacement therapy.
Behavioral: Multidisciplinary team (MDT) care and Acute kidney disease (AKD) clinic
No intervention: Usual care Participants randomized to this arm will receive usual care according to the medical decisions of principal care physician. Nephrologist consultation and nephrology outpatient clinic follow-up will be allowed. However, this group of patient will not have access to MDT care and AKD clinic.
Multidisciplinary team (MDT) care: NPDS care model Acute kidney disease (AKD) clinic: layered approach
Proportion of Major adverse kidney event
Proportion of MAKE * Renal progression to CKD * Chronic dialysis (any 1 outpatient dialysis after discharge) * Death
Time frame: 90days
Mortality
Proportion of death
Time frame: 30days, 60days, 90days, 180days, 360 days, 3years
Chronic dialysis
Proportion of chronic dialysis
Time frame: 90days, 180days, 360 days, 3years
Renal progression
Proportion of renal progression to CKD
Time frame: 90days, 180days, 360 days, 3years
Time to MAKE
Time to MAKE
Time frame: 90days, 180days, 1year (360days)
Time to death
Time to death
Time frame: 90days, 180days, 1year (360days)
Time to chronic dialysis
Time to chronic dialysis
Time frame: 90days, 180days, 1year (360days)
Time to renal progression to CKD
Time to renal progression to CKD
Time frame: 90days, 180days, 1year (360days)
Time to first ER visit
Time to first ER visit
Time frame: 90days, 180days, 1year (360days)
Time to first rehospitalization
Time to first rehospitalization
Time frame: 90days, 180days, 1year (360days)
Time to first recurrence of AKI
Time to first recurrence of AKI
Time frame: 90days, 180days, 1year (360days)
Proportion of MACE
CVA, AMI, CHF, or cardiac revascularization procedure
Time frame: 30days, 60days, 90days, 180days, 360 days, 3years
No study locations are listed for this record.
Plan to share: Undecided — Undecided
This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taipei Medical University Shuang Ho Hospital